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ABSTRACT       
 
Although full-term pregnancies reduce the risk of ovarian cancer, whether incomplete 
pregnancies also influence risk is not established.  We investigated the relationship 
between a history of incomplete pregnancy and incident epithelial ovarian cancer.  
Participants in two large Australian population-based case-control studies in 1990 - 
1993 and 2002 -2005 (2,300 incident cases and 2,263 controls) provided responses to a 
range of questions about their reproductive histories.  Summary odds ratios (OR) and 
confidence intervals (CI) were derived from multivariate analysis of each study using the 
same covariates.  Logistic coefficients (log(OR)) for each of the studies were 
aggregated using inverse variance weights before exponentiation.  A systematic review 
of studies (1966-2007) of incomplete pregnancies and risk of ovarian cancer was also 
undertaken.  The authors’ own studies demonstrated no statistically significant 
associations in relation to incomplete pregnancy (either spontaneous or induced 
miscarriageabortion) and ovarian cancer, irrespective of previous childbirth, consistent 
with the net findings of 37 studies in the systematic review.  Further, there were no clear 
differences in risk of ovarian cancer between women with a history of spontaneous 
compared with induced miscarriageabortion.  It is concluded that a history of incomplete 
pregnancy does not influence a woman’s risk of epithelial ovarian cancer. 
(word count  197 ) 
 
Key words (MeSH):  Abortion, Spontaneous, Abortion, Induced, Ovarian Neoplasms, 
Risk, Carcinoma 
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INTRODUCTION 
In the United States of America,(1)(1) the United Kingdom(2)(2) and Australia,(3)(3) 
ovarian cancer is the most common cause of death from gynaecological malignancy, 
and responsible for high burdens of cancer mortality.  Unfortunately, effective screening 
mechanisms for ovarian cancer have yet to be established, and determinants of 
epithelial ovarian cancer (EOC) – the most common type of ovarian cancer – have to 
date only partially been identified. 
 
Increasing number of childbirths (parity) is known to reduce risk of EOC,(4)(4) and the 
protection conferred is in keeping with the mechanisms proposed by two major 
hypotheses to explain the pathogenesis of ovarian cancer.  The incessant ovulation 
theory proposes that disruption to the outer epithelial cells of the ovary at the time of 
ovulation may lead to malignant transformation,(5)(5) while the pituitary hormone 
gonadotrophin ovarian stimulation theory proposes that the continual monthly 
stimulation of the ovary by gonadotrophins contributes to the development of malignant 
change.(6)(6)  If full-term pregnancies reduce the risk of ovarian cancer by either 
mechanism, it is reasonable to hypothesise that incomplete pregnancies might also, 
though perhaps to a lesser extent.   
 
Previous publications have explored the relationship of incomplete pregnancies and risk 
of ovarian cancer, however reported results vary according to the reference group and 
definitions used during analysis, and the extent of adjustment for other factors.  Also, 
many of the results have been based on hospital-based studies, with few population-
based studies.  Some studies have shown a significant reduction in risk of ovarian 
cancer, some a significant increase in risk, and many others have shown no effect.   
 
Comment [m1]: Reviewer 2, point 3. 
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This paper analyses data from two large Australian case-control studies of ovarian 
cancer (hereafter referred to as Studies 1 and 2), and sets the findings in the context of 
other identifiable published studies in order to determine the association between 
incomplete pregnancies and EOC as comprehensively as possible.   
 
MATERIALS AND METHODS  
Subjects 
Study 1.: A detailed description of the study has been published.(7)(7)  In brief, all 
incident cases of histologically confirmed primary EOC in women aged 18-79 years 
treated in the major gynaecologic-oncology treatment centres of three Australian States 
(and additionally those identified from the cancer registry in Queensland) were included 
in the study.   For New South Wales and Victoria, women diagnosed in 1991 and 1992 
were included, whilstwhile in Queensland, incident cases from late 1990 through 1993 
were enrolled (7)(7).  Controls were randomly selected from State and Commonwealth 
electoral rolls, according to the ages and geographic distributions of cases.  Electoral 
enrolment in Australia is compulsory by law, with coverage estimated to be 97% (8)(8).   
 
Study 2.   A detailed description of the study methodology has been published (9)(9).  In 
brief, women aged 18-79 years with newly diagnosed histologically confirmed EOC were 
recruited primarily from specialized gynaecologic-oncology units between January 2002 
and June 2005.  Women missed at treatment centers were identified through state-
based cancer registries and invited to participate.  Controls were women aged 18-79 
years randomly selected from the Australian Electoral Roll, frequency matched to the 
entire case series by age (in five-year groups) and state of residence.   
 
All women gave their written informed consent prior to their participation. The studies 
were approved by the Human Research Ethics Committees at all participating hospitals 
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and cancer registries, and at the Queensland Institute of Medical Research, and also for 
Study 2, at the Peter MacCallum Cancer Centre and the University of Melbourne.. 
 
In Study 1, there were 1,116 cases of incident epithelial ovarian cancer originally 
identified and 1,527 women whose names were randomly selected from the electoral 
roll, whilstwhile in Study 2, there were 3,553 women initially identified with suspected 
ovarian cancer (many women were approached prior to surgery and thus before 
histological confirmation), and 3,600 women randomly selected from the electoral roll.  
Following exclusions (due to ineligible age, ineligible tumor histology, inability to be 
contacted, etc) response rates of eligible participants were 95% (794/835) for cases and 
73% (855/1173) for controls in Study 1 and 94% (1580/1685) for cases and 45% 
(1509/3339) for controls in Study 2. After further excluding women with missing 
reproductive information in their surveys, a total of 2,300 cases of epithelial ovarian 
cancer (792 from Study 1 and 1508 from Study 2) and 2,263 controls (853 from Study 1 
and 1410 from Study 2) were available for the analysis of incomplete pregnancies in 
relation to ovarian cancer.   
 
Data Collection 
Study 1.  All women participated in a face-to-face interview with a trained interviewer 
and provided responses to a range of questions about reproductive, sociodemographic, 
medical, lifestyle and environmental factors.  In the Pregnancy and Breastfeeding 
Calendar section of the questionnaire, women were asked to report whether they had 
had any past pregnancies, and if so, whether the pregnancies had ended as 
‘miscarriage’, ‘induced abortion’, ‘stillbirth’, ‘live birth’ or ‘other’. The duration (in months) 
of any pregnancies was sought, and women also recorded the date (month and year) of 
each pregnancy outcome in the Pregnancy and Contraceptive Calendar section of the 
 7 
questionnaire. Information recorded in the two calendars was crosschecked for 
consistency of responses.   
 
The words ‘miscarriage’ and ‘abortion’ as they apply to incomplete pregnancies are 
used variably in the medical literature and in the general community.  Sometimes these 
terms are used interchangeably but at other times to distinguish whether the premature 
ending of a pregnancy occurred naturally (spontaneously) or was induced.  Except when 
citing results from other studies, we use the word ‘miscarriage’ abortion’ throughout this 
manuscript to indicate a pregnancy that ended prematurely, and preface the word with 
“spontaneous” or “induced” when a distinction in meaning between the two methods of 
premature ending of the pregnancy is required.  We use the term ‘incomplete 
pregnancy’ to refer to either a spontaneous or an induced miscarriageabortion, including 
ectopic pregnancy.   
 
Women’s responses regarding outcomes of past pregnancies were examined, and any 
responses of ‘other’ to the outcomes question that satisfied the definition of 
spontaneous or induced miscarriage abortion were re-classified.  Scrutiny of responses 
also demonstrated that some women reported a history of “miscarriage” when they had 
experienced an ectopic pregnancy, whilstwhile others referred to ectopic pregnancies as 
“other” pregnancies.  Ectopic pregnancies were excluded from the “spontaneous 
miscarriageabortion” class, but included in the “incomplete pregnancy” class (15 women 
– 7 cases and 8 controls - had at least one ectopic pregnancy).  The number of 
incomplete pregnancies was derived as the sum of the number of spontaneous 
miscarriagesabortions, terminations induced abortions and ectopic pregnancies. 
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Study 2.  As for Study 1, all participants were asked to complete a health and lifestyle 
questionnaire, including demographic characteristics and detailed questions regarding 
medical, reproductive and contraceptive histories, however Study 2 participants were 
asked to self-administer the questionnaires.  Where possible, missing information and / 
or inconsistencies were clarified by research nurses in a follow-up telephone interview.  
Reported ectopic pregnancies were handled as in Study 1.  Forty-one women (19 cases 
and 22 controls) had at least one ectopic pregnancy. 
 
Dates of pregnancies were not always listed in chronological order in completed 
questionnaires and dates of incomplete pregnancies were frequently not listed. Where 
there was at least one incomplete pregnancy of unknown date, the variables ‘age at 
first/last miscarriage/abortion/incomplete pregnancy”, “first 
miscarriage/abortion/incomplete pregnancy before/after first full-term pregnancy” and 
“duration of first miscarriage/abortion/incomplete pregnancy” were derived wherever 
possible by inspection of the set of responses to the question seeking detailed 
information regarding each of the pregnancies.  Undated terminations listed after a 
number of live births were also assumed to be in correct order. If dates of birth were not 
listed in ascending order, no such decision was made. There were in consequence an 
appreciable number of missing values for these outcome variables in Study 2, whereas 
in Study 1 almost all data collected in the face-to-face interviews could be assigned to 
“age at first/last miscarriage/abortion/incomplete pregnancy” categories.  
 
Statistical Analysis 
Our major aims were to determine the associations between incomplete pregnancy 
(either spontaneous miscarriageabortion, induced miscarriageabortion, or both) and 
epithelial ovarian cancer overall, and separate amongstamong women without children 
(i.e. nulliparous women) and also amongstamong women who had given birth (i.e. 
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parous women).   For each of Studies 1 and 2, conditional logistic regression, 
conditioning on strata of age in years, was used to calculate the odds ratios (OR) 
(estimated relative risks) and 95% confidence intervals (CI) for ovarian cancer 
associated with aspects of incomplete pregnancy, and spontaneous and induced 
miscarriageabortion.   The specific variables examined were: number of incomplete 
pregnancies (0, 1, 2, 3+), spontaneous miscarriages abortions (0, 1, 2, 3+) and induced 
miscarriages abortions (0, 1, 2+);  age at first and last incomplete pregnancy or 
miscarriage abortion (<20, 20-29, 30+);  timing of first incomplete pregnancy or 
miscarriage abortion relative to first full-time birth; and gestational length of first 
incomplete pregnancy / miscarriage abortion (≤ 2, > 2 months).  Where data were too 
sparse, categories were combined. 
 
The following factors were associated to some degree with the number of incomplete 
pregnancies in parous or nulliparous cases or controls in either / both data sets and 
were controlled for in the conditional logistic analyses:  duration of oral contraceptive 
(OC) use in years; history of tubal ligation; history of hysterectomy; smoking status 
(current, past, never); average daily alcohol consumption (none, 0.1-2.5g, or > 2.5g); 
menopausal status, and for parous women: age at last birth (less than 30 years, or 30 or 
more years) and number of births (1, 2, 3, 4, 5 or more).  Preliminary inclusion of the 
covariables for education and State of residence made no material difference to the 
results/odds ratios and so was not included in the final conditional logistic analyses.  
 
Summary ORs and CIs were derived from the separate multivariate analyses on the two 
data sets, using identical sets of covariates. Logistic coefficients (log(OR)) for each of 
the case control studies were aggregated using inverse variance weights before 
exponentiation. 
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Systematic Review 
PubMed software was used to search Medline (U.S. National Library of Medicine, 
Bethesda, MD) (1966 – September 2007) to identify published articles exploring the 
association of incomplete pregnancies / miscarriage / abortion with ovarian cancer.  
Reference lists in relevant publications were also reviewed to identify any further 
articles.  Where multiple reports from one study were found, we included the report that 
was incorporated into a pooled analysis (if available), or alternatively the report 
containing data for the greatest number of ovarian cancer cases.   Where more than one 
risk estimate was given, those adjusted for the greatest number of potential confounding 
variables were included. 
 
 
RESULTS 
 
Baseline demographic data for cases and controls from both studies have been reported 
elsewhere (7, 9)(7, 9). 
 
A total of 1,490 women (33%) - 762 (33%) cases and 728 (32%) controls - reported 
having ever had an incomplete pregnancy (i.e. one or more spontaneous and/or induced 
miscarriageabortion) (Table 1).  A total of 1105 women (24%) - 570 (25%) cases and 
535 (24%) controls - reported at least one spontaneous miscarriageabortion, whilstwhile 
476 women (11%) - 246 cases (11%) and 230 controls (10%) - reported at least one 
induced miscarriage abortion (Tables 2 and 3).  
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Overall no statistically significant associations were seen in relation to incomplete 
pregnancy (and either spontaneous or induced miscarriageabortion) and ovarian cancer 
risk, in either parous or nulliparous women.  Additionally, no statistically significant 
associations were identified in relation to gestational length of first incomplete 
pregnancy (or spontaneous or induced abortionmiscarriage), timing of first incomplete 
pregnancy (or spontaneous or induced abortionmiscarriage) relative to first full-term 
birth, or age at last incomplete pregnancy (or spontaneous or induced 
abortionmiscarriage).  The median duration of incomplete pregnancy was 2 months. 
 
The only findings approaching statistical significance were an increased risk of ovarian 
cancer in parous women whose age at first spontaneous abortion miscarriage or last 
spontaneous abortion miscarriage was less than 20 years (OR = 1.66, CI: 1.00, 2.8 and 
OR = 2.0, CI: 0.99, 4.1 respectively) (Table 3). This pattern was also seen in nulliparous 
women whose age at first or last spontaneous abortion miscarriage was less than 29, 
but was not significant (OR = 1.52, CI:0.59, 3.9 and OR = 1.71, CI: 0.60, 4.9)   These 
trends were not seen in parous women with induced abortionmiscarriage, and a non-
significant reduction in risk was seen for nulliparous women with induced abortion 
miscarriage (Table 3). 
 
The Medline search identified 37 studies that reported risk of ovarian cancer associated 
with incomplete pregnancy : 16 population-based studies (2 cohort studies (10, 11)(10, 
11) and 14 case-control studies (12-25)(12-25)); 20 hospital-based case-control studies 
(26-45)(26-45); and one case-control study with equal numbers of population and 
hospital-based controls (46)(46).  The results of 6 USA population-based case-control 
studies (12, 15, 18, 22, 24, 25)(12, 15, 18, 22, 24, 25) and 5 USA hospital-based studies 
(28, 32, 33, 35, 42)(28, 32, 33, 35, 42) were pooled in a review by Whittemore et al. 
1992 (4)(4).  The results of 3 hospital-based case control studies based in Italy (37)(37), 
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the United Kingdom (27)(27) and Greece (40)(40) were pooled in a review by Negri et 
al. 1991(47)(47).  These pooled results are included in the systematic review rather than 
individual study results.  Key results from the population-based studies and hospital-
based studies are presented in Tables 4 and 5 respectively, together with the results of 
the present study (Table 4). Four studies did not report odds ratios, (34, 41, 43, 46)(34, 
41, 43, 46)    however estimated odds ratios and confidence intervals were able to be 
calculated for three of these studies from data provided in their manuscripts (34, 43, 
46)(34, 43, 46). 
The studies varied substantially according to several factors: whether they reported data 
relating to incomplete pregnancies, and/or spontaneous abortionsmiscarriages, and/ or 
induced miscarriages (or abortions); the reference groups against which these 
outcomes were compared; the histological types of ovarian cancer; whether they were 
stratified by parity; and also with respect to the variables adjusted for in their analyses.  
Thus they were not all directly comparable.  Despite this however, it is possible to 
summarise the data by stating that there is no convincing reproducible evidence that 
incomplete pregnancies or spontaneous or induced abortionsmiscarriages, materially 
increase or decrease risk of ovarian cancer.   
 
WhilstWhile a number of studies showed some non significant trends in ovarian cancer 
risk (in both directions), only one of the population based studies(19)(19), 5 of the 
hospital-based studies and the pooled analysis of 3 hospital-based studies 
demonstrated associations with  statistical significance.  Neither of the 2 cohort studies 
demonstrated any association between incomplete abortion miscarriage and ovarian 
cancer risk. (Tables 4 and 5) 
 
The population-based case-control study described by Riman et al. (2002) (19)(19) 
reported a 24% reduction in risk of invasive epithelial ovarian cancer for women with a 
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history of one ‘incomplete pregnancy’ (OR = 0.76, CI 0.59-0.98); the risk reduced further 
for women having had 2 or more “incomplete pregnancies”, but this did not reach 
statistical significance (OR = 0.70, CI: 0.44, 1.12) (Table 4). 
 
With respect to the case-control studies, El-Khwsky et al, 2006 (30)(30) showed an 
increase in risk of ovarian cancer with one or more “fetal losses” (OR = 1.7, CI: 1.16, 
2.59 for one to three “fetal losses” and OR = 3.7, CI: 1.02, 13.45 for four or more 
losses), Bernal et al., 1995 (26)(26) reported an 82% increase in risk for women having 
had one or more “abortions”, and calculations from data published by Wynder et al., 
1969 (43)(43) gave an estimated increase in risk of 69% for women having one or more 
spontaneous abortions (OR = 1.69, CI: 1.03, 2.76).  Conversely, Mori et al. 1988 
(36)(36) reported a 40% reduction in risk of ovarian cancer for women having had an 
“induced abortion” (OR = 0.6, p = 0.04) (36)(36), and Zhang et al., 2004 reported a 44% 
reduction in risk for women with two or more incomplete pregnancies (OR = 0.56, CI: 
0.39, 0.82).  Negri et al. 1991(47)(47)  in their pooled analysis of three studies (27, 37, 
40)(27, 37, 40), reported a 30% reduction in risk for women with a history of 2 or more 
“abortions” (OR = 0.7, CI: 0.6, 0.9) (Table 5). 
 
In addition to our own study, several studies explored associations between incomplete 
pregnancies and ovarian cancer specifically for nulliparous women (4, 13, 16, 47)(4, 13, 
16, 47), and no statistically significant associations were identified.  For parous women, 
Negri et al. (1991) (47)(47) reported a 30% reduction in risk for ovarian cancer in women 
who had had two or more “abortions” (OR = 0.7, CI: 0.0.5, 0.9), whilstwhile Bernal et al. 
(1995) (26)(26) reported a 100% increase in risk of ovarian cancer with one to three 
“abortions” (OR = 2.05, CI: 1.33, 3.16) and an even greater risk with four “abortions” 
(OR = 5.44, CI: 1.43, 22.28).  Chen et al. 1996 (13)(13), Risch et al. 1994 (20)(20) and 
Shu et al. 1989 (21)(21) did not find any significant associations.   
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Discussion 
 
The Our results of our case-control studies are based on 2,300 cases of epithelial 
ovarian cancer from two of the largest ovarian case control studies ever undertaken that 
explore the association of incomplete miscarriage and ovarian cancer risk .  No 
statistically significant association was found between either spontaneous or induced 
abortionmiscarriage, and ovarian cancer.  This absence of association persisted after 
considering such factors as timing of first incomplete pregnancy / abortion miscarriage in 
relation to first full-term birth, gestational length of first incomplete pregnancy / abortion 
miscarriage and parity.   
 
We do not have a biological explanation for our study’s isolated finding of an increased 
risk of ovarian cancer in parous women whose age at first spontaneous abortion 
miscarriage or last spontaneous abortion miscarriage was less than 20 years (Table 2 – 
based on 33 cases and 38 controls), and indeed it is possibly a chance finding given the 
large number of statistical tests performed. Chen et al., 1996 report a statistically 
significant increased risk of ovarian cancer in every-pregnant women whose age at first 
spontaneous abortion was less than 20 years (OR = 3.1, CI: 1.3, 7.8). (13) These 
findings are based on 14 cases and 9 controls.  Gierach et al. 2004 however report a 
non significant reduction in risk of ovarian cancer among gravid women with a history of 
incomplete pregnancy with a first incomplete pregnancy at age less than 25 years. (16)  
 
The systematic review identified 37 relevant epidemiological studies.  WhilstWhile the 
studies are not all directly comparable due to their variability with respect to such factors 
as their outcome measures, the reference groups against which their outcomes were 
compared, and the variables adjusted for in their analyses, the absence of a significant 
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association between incomplete pregnancies (including spontaneous and/or induced 
abortionsmiscarriages) and ovarian cancer was demonstrated for the large majority of 
studies identified in the systematic review.    Of the small number of studies reporting a 
statistically significant association, some reported a reduced risk of ovarian cancer, 
whilstwhile others reported an increase in risk.  The pooled analysis of 3 hospital-based 
studies by Negri et al. 1991 (47)(47), the hospital-based studies by Mori et al. 1988 
(36)(36), and Zhang et al. 2004(45)(45) and the population-based study by Riman et al. 
2002 (19)(19) showed a reduction in risk of ovarian cancer in all women (or ever married 
women for Mori et al.) with ”abortion”, ”induced abortion”, “incomplete pregnancies” and 
”abortions – spontaneous or induced” respectively, whilstwhile the hospital-based case-
control studies by El-Khwsky et al. 2006 (30)(30) and Bernal et al. 1995 (26)(26) 
reported an increase in risk of ovarian cancer in women with one or more “fetal losses” 
or ”abortions” respectively.(Tables 4 and 5).  Furthermore, our study and the systematic 
review did not identify any substantial differences in risk of ovarian cancer between 
women with a history of spontaneous abortion miscarriage and women with a history of 
induced abortionmiscarriage, nor between parous and nulliparous women. 
 
 The predominant absence of any significant risk of ovarian cancer with incomplete 
pregnancy does not lend support to the hypothesis that incomplete pregnancies may 
confer (albeit to a lesser extent) a protective effect similar to that noted with full-term 
pregnancies.  Nor does it lend support to a proposed mechanism that the recovery of 
equilibrium in the reproductive organs following pregnancy interruption could be a risk 
for ovarian cancer. (26) It may be that any true risk due to incomplete pregnancies (the 
vast majority of which are less than 3 months in duration) is of insufficient magnitude 
compared with associations with live births to be detectable at a level of statistical 
significance in case-control studies.  
 
Comment [m4]: An attempt to briefly 
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While it is a limitation that Study 2 had a lower response rate for controls and less 
accurate information on incomplete pregnancies than Study 1, it is of note that there 
were no major differences in findings between the two studies.   
 
We consider it unlikely that poor recall explains the lack of association since previous 
studies have shown that menstrual and reproductive events can be recalled with 
reasonable accuracy (48, 49)(48, 49), and the value of calendars as used in our studies 
to assist recall (for example by first recalling significant “landmark events”(50)(50)) has 
been supported by a strong body of evidence (51)(51). Missing dates for some of the 
incomplete pregnancies in Study 2, and the subsequent decisions made by the research 
team in determining the chronological order of pregnancies based on inspection of 
participant responses to other reproductive questions in the questionnaire, could result 
in misclassification error.  WhilstWhile any such error might influence variables exploring 
the timing of the incomplete pregnancy, it should not impact upon the total numbers of 
incomplete pregnancies reported. 
 
Induced abortion miscarriage is a sensitive issue for women, and it is possible that 
women may under-report their experience of induced miscarriage due to social stigma 
and legality issues.(52-54)(52-54)  Such under-reporting may occur among both cases 
and controls. WhilstWhile recent research suggests that under-reporting does not differ 
between cases and controls,(55)(55) others suggest controls are more likely to under-
report, with cases being more prepared to report details about any factors which may 
have contributed to the development of their disease (rumination bias).(56)(56)  Our 
results showed no significant differences in reporting of induced abortion miscarriage 
between cases and controls.  Differential under-reporting by controls would if anything, 
move our estimated effect of incomplete pregnancies on ovarian cancer risk in the 
direction of being more protective.  Non-differential under-reporting of induced abortion 
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miscarriage however, would result in a weakening of any true effect, and our observed 
results might then be masking a very small association of abortion miscarriage with 
ovarian cancer, the direction of which is impossible to determine.  Ideally this issue 
could be overcome if a prospective study were conducted in regions where all 
miscarriages and terminationsspontaneous and induced abortions were recorded in a 
register as they occurred.  Unfortunately there is no accurate national data on the 
prevalence of past abortions with which to compare our study results.   
 
 
The potential association of ovarian cancer with occult miscarriages / abortions (i.e. 
those miscarriages that occur so early in the course of the pregnancy that they go 
unnoticed by women, and are often considered to be their own natural or slightly late 
menstrual cycle) is not possible to measure.  If ovarian cancer risk were linked with 
suppression of ovulations, then any reduction in risk attributable to occult miscarriages 
is unlikely to be of sufficient size in case-control studies to contribute substantially to any 
observed association, since occult miscarriages are of less than 2 months duration. 
 
 
In summary, the results of our own large studies and those results of 37 other relevant 
population and hospital-based studies provide reasonably consistent evidence of the 
absence of an effect of incomplete pregnancy (either spontaneous or induced abortion 
or both) on ovarian cancer risk.   These results may be reassuring to women with a 
history of incomplete pregnancy that they are at no greater risk of ovarian cancer than 
other women as a result of this history.  
 
Acknowledgments 
 
Comment [m6]: Reviewer 1, point 2. 
 18 
Funding for Case Control Study 1 was provided by the Australian National Health and 
Medical Research Council and the Queensland Cancer Fund, and for Case Control 
Study 2 by the U.S Army Medical Research and Materiel Command, the National Health 
and Medical Research Council of Australia, the Cancer Council Tasmania and the 
Cancer Foundation of Western Australia.   The contributions of study participants and 
members of the Survey of Women’s Health Study and the Australian Ovarian Cancer 
Study Group is gratefully acknowledged.  
 
The Australian Ovarian Cancer Study Group comprises:  
Management Group: D Bowtell (Peter MacCallum Cancer Centre, PMCC), G Chenevix-
Trench, A Green, P Webb (Queensland Institute of Medical Research, QIMR), A 
deFazio (Westmead Hospital), D Gertig (University of Melbourne). Project Managers: N 
Traficante (PMCC), S Moore (QIMR), J Hung (Westmead Hospital). Data Managers: S 
Fereday (PMCC), K Harrap, T Sadkowsky (QIMR). Research Nurses: NSW- A Mellon, R 
Robertson (John Hunter Hospital), T Vanden Bergh (Royal Hospital for Women), J 
Maidens (Royal North Shore Hospital), K Nattress (Royal Prince Alfred Hospital), YE 
Chiew, A Stenlake, H Sullivan, (Westmead Hospital); QLD- B Alexander, P Ashover, S 
Brown, T Corrish, L Green, L Jackman, K Martin, B Ranieri (QIMR); SA- J White 
(QIMR); TAS- V Jayde (Royal Hobart Hospital); VIC- L Bowes (PMCC), P Mamers 
(Monash Medical Centre), WA- T Schmidt, H Shirley, S Viduka, Hoa Tran, Sanela Bilic , 
Lydia Glavinas (Western Australia Research Tissue Network). Clinical Collaborators: 
NSW- A Proietto, S Braye, G Otton (John Hunter Hospital); T Bonaventura, J Stewart 
(Newcastle Mater Misericordiae); M Friedlander (Prince of Wales Hospital); D Bell, S 
Baron-Hay, A Ferrier, G Gard, D Nevell, B Young (until mid 2003) (Royal North Shore 
Hospital); C Camaris, R Crouch, L Edwards, N Hacker, D Marsden, G Robertson (Royal 
Hospital for Women); P Beale, J Beith, J Carter, C Dalrymple, A Hamilton, R Houghton, 
P Russell (Royal Prince Alfred Hospital); A Brand, R Jaworski, P Harnett, G Wain 
 19 
(Westmead Hospital); QLD- A Crandon, M Cummings, K Horwood. A Obermair, D Wyld 
(Royal Brisbane and Women’s Hospital, RBWH); J Nicklin (RBWH and Wesley 
Hospital), L Perrin (RBWH and Mater Misericordiae Hospitals), B Ward (Mater 
Misericordiae Hospitals); SA- M Davy, C Hall, T Dodd, T Healy, K Pittman (Royal 
Adelaide Hospital, Burnside Memorial Hospital); D Henderson, S Hyde (Flinders Medical 
Centre); J Miller, J Pierdes (Queen Elizabeth Hospital) TAS- P Blomfield, D Challis, R 
McIntosh, A Parker (Royal Hobart Hospital); VIC- B Brown, R Rome (Freemasons 
Hospital); D Allen, P Grant, S Hyde, R Laurie M Robbie, (Mercy Hospital for Women), D 
Healy, T Jobling, T Maniolitas, J McNealage, P Rogers, B Susil, A Veitch, J Constable, 
S Ping Tong, I Robinson, I Simpson, (Monash Medical Centre); K Phillips, D Rischin, P 
Waring, M Loughrey, N O’Callaghan, Bill Murray (PMCC); V Billson, S Galloway, J 
Pyman, M Quinn  (Royal Women’s Hospital); WA- I Hammond, A McCartney, Y Leung  
(King Edward Memorial Hospital, St John of God). Scientific Collaborators: I Haviv 
(PMCC); D Purdie, D Whiteman (QIMR); N Zeps (WARTN) 
 
The Australian Cancer Study Group investigators are:  
AC Green, PG Parsons, N Hayward, P Webb, D Purdie, D Whiteman (QIMR) 
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Table 1.  Estimated Relative Risk of Ovarian Cancer Associated With Incomplete Pregnancy (One or More Spontaneous 
and/or Induced MiscarriageAbortion), by Parity Status, Australia, 1990 - 1993 and 2002 -2005.  
 
  Case Control Study 1  Case Control Study 2  Both Studiesa,b   
  Cases Controls  Cases Controls    
Parity Status Variable n % n %  n % n %  OR 95% CI 
Parous Number of incomplete pregnancies 
 0 c  416 67.1 469 64.9  842 63.4 730 63.6  1.0  
 1 140 22.6 167 23.1  301 22.7 257 22.4 1.02 0.86, 1.20 
 2 32 5.2 49 6.8  123  9.3 100  8.7  0.90 0.70, 1.17 
 3+ 32 5.2 38 5.2   61  4.6  61  5.3  0.93 0.68, 1.28 
 QuantiativedT
rend in riskd 
      0.99 0.93, 1.06 
              
 Age at first incomplete pregnancy 
 < 20 23 11.4 23 9.1   54 12.4  58 16.2  1.38 0.98, 1.95 
 20-29 113 55.9 166 65.4  252 57.8 192 53.8  0.87 0.73, 1.03 
 30+ 66 32.7 65 25.6  130 29.8 107 30.0  1.06 0.84, 1.35 
       
 Age at last incomplete pregnancy 
 < 20 11  5.5 12  4.7  24 5.5 31 8.6 1.66 1.03, 2.7 
 20-29 106 52.7 140 55.1  233 53.4 185 51.5  0.96 0.80, 1.15 
 30+  84 41.8 102 40.2  179 41.1 143 39.8  0.93 0.76, 1.15 
              
 Timing of first incomplete pregnancy relative to first full-term birth
 Before  70 34.3  93 32.7  163 37.8 129 37.0  0.97 0.78, 1.21 
 After 134 65.7 161 67.3  268 62.2 220 63.0  0.97 0.81, 1.15 
       
 Gestational length of first incomplete pregnancy 
 ≤ 2 months 132 66.3 162 65.3  229 59.5 167 51.7  0.94 0.78, 1.12 
 > 2 months  67 33.7  86 34.7  156 40.5 156 48.3 1.16 0.93, 1.43 
              
Nulliparous Number of incomplete pregnancies 
 0c 144 83.7 118 90.8  136 75.1 218 83.2  1.0  
 1  16  9.3 9  6.9   26 14.4  20  7.6  0.72 0.40, 1.29 
 2   12   7.0 3  2.3   19 10.5  24  9.2  1.14 0.60, 2.2 
 Trend in 
riskQuantiati
ved 
      1.05 0.85, 1.28 
              
 Age at first incomplete pregnancy 
 < 20    4 14.3  0   0.0     8 19.5    9 24.3 
 20-29  16 57.1 10  83.3   27 65.9  22 58.5  0.98 0.59, 1.63 
 30+   8 28.6  2  16.7     6 14.6    6 16.2  0.76 0.28, 2.1 
              
 Age at last incomplete pregnancy 
 < 20  3 10.7  0  0.0    4  9.5    6 15.8 
 20-29 13 46.4  8 66.7   25 59.5  17 44.7  0.81 0.44, 1.49 
 30+ 12 42.9  4 33.3  13 31.0  15 39.5  0.90 0.45, 1.82 
       
 Gestational length of first incomplete pregnancy 
 ≤ 2 months 20 71.4  8 66.7   24 61.5  24 68.6  1.07 0.60, 1.91 
 > 2 months  8 28.6  4 33.3  15 38.5 11 31.4 0.74 0.35, 1.58 
              
CI=95% Confidence Interval; OR=Odds Ratio..  
a No deviance differences, with degrees of freedom, approached significance. 
b Conditional logistic analysis controlled for duration of OC use in years, tubal ligation, hysterectomy, smoking, alcohol use, parity 
(1,2,3,4,5+), menopausal status, age at last birth >/= 30 years. 
c Reference category for all odds ratios  
d Per incomplete pregnancy  
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Table 2.  Estimated Relative Risk of Ovarian Cancer Associated With Spontaneous Miscarriage Abortion by Parity Status, 
Australia, 1990 - 1993 and 2002 -2005.  
 
  Case Control Study 1  Case Control Study 2  Both Studiesa,b   
  Cases Controls  Cases Controls    
Parity Status Variable n % n %  n % n %  OR 95% CI 
Parous Number of spontaneous miscarriagesabortions 
 0c 443 71.5 514 71.1  958 72.2 844 73.5  1.0  
 1 134 21.6 148 20.5  255 19.2 202 17.6 0.97 0.80, 1.17 
 2  22  3.6  33  4.6   74  5.6  62  5.4  0.93 0.75, 1.15 
 3+  21  3.3  28  3.9   40  3.0  40  3.5  0.94 0.61, 1.46 
 Trend in 
riskQuantiati
ved 
      0.97 0.90, 1.04 
              
 Age at first spontaneous miscarriageabortion 
 < 20  15  8.5  11   5.3   18  5.4  27 10.4  1.66 1.00, 2.8 
 20-29 100 56.5 146 69.9  199 60.0 151 58.1  0.86 0.71, 1.04 
 30+  62 35.0  52 24.9  115 42.6 82 31.5 1.04 0.80, 1.35 
              
 Age at last spontaneous miscarriageabortion 
 < 20  10  5.6  9   4.3     6  1.8  14  5.4  2.0 0.99, 4.1 
 20-29  97 54.8 124 59.3  185 55.6 147 56.5  0.95 0.78, 1.15 
 30+  70 39.5  76 33.4  142 42.6  99 38.1  0.89 0.70, 1.12 
              
 Timing of first spontaneous miscarriage abortion relative to first full-term birth
 Before  56  31.6  75 35.9  102 30.7  80 22.3  0.91 0.71, 1.17 
 After 121  68.4 134 64.1  230 69.3 180 77.7 1.02 0.81, 1.27 
              
 Gestational length of first spontaneous miscarriageabortion
 ≤ 2 months 107 60.5 131 62.1  148 50.5 102 43.0 0.89 0.72, 1.09 
 > 2 months  70 39.5  80 37.9  155 49.5 135 57.0  1.08 0.87, 1.34 
              
Nulliparous Number of spontaneous miscarriagesabortions 
 0c 160 93.0 124 95.4  169 93.3 246 93.9  1.0  
 1  10  5.8    4  3.1     7  3.9    7  2.7  0.89 0.35, 2.3 
 2   2  1.2    2  1.5     5  2.8    9  3.4  1.05 0.36, 3.1 
 Trend in 
riskQuantiati
ved 
          1.11 0.76, 1.61 
              
 Age at first spontaneous miscarriageabortion 
 < 20    2 16.7    0  0.0     0     3 21.4    
 20-29    6 50.0     4 66.7     6 60.0    7 50.0  1.52 0.59, 3.9 
 30+    4 33.3      2 33.3     4 40.0    4 28.6  0.72 0.22, 2.4 
              
 Age at last spontaneous miscarriageabortion 
 < 20    2 16.7   0   0  1  7.1    
 20-29    6 50.0   3 50.0  5 50.0 6 42.9  1.71 0.60, 4.9 
 30+    4 33.3    3 50.0  5 50.0 7 50.0  0.77 0.27, 2.2 
       
 Gestational length of first spontaneous miscarriageabortion
 ≤ 2 months   9 75.0   4  66.7     5 50.0  10 71.4  1.78 0.70, 4.6 
 > 2 months   3 25.0   2 33.3     5 50.0    4 28.6  0.49 0.14, 1.67 
              
CI=95% Confidence Interval; OR=Odds Ratio..  
a No deviance differences, with degrees of freedom, approached significance. 
b  Conditional logistic analysis controlled for duration of OC use in years, tubal ligation, hysterectomy, smoking, alcohol use, parity 
(1,2,3,4,5+), menopausal status, age at last birth >/= 30 years. 
c Reference category for all odds ratios  
d  Per spontaneous miscarriage abortion  
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Table 3.  Estimated Relative Risk of Ovarian Cancer Associated With Induced Miscarriage Abortion by Parity Status, 
Australia, 1990 - 1993 and 2002 -2005.  
 
  Case Control Study 1  Case Control Study 2  Both Studiesa,b     
  Cases Controls  Cases Controls    
Parity 
Status 
Variable n % n %  n % n %  OR 95% CI 
Parous Number of induced miscarriagesabortions 
 0c 580 93.5 670 92.7  1173 88.4 1007 87.7 1.0  
 1  22  3.6  38  5.3   114  8.6   98  8.5  1.08 0.82, 1.41 
 2  18  2.9  15  2.1    40  3.0   43  3.7  1.22 0.80, 1.84 
 Trend in 
riskQuantiati
ved 
     1.08 0.94, 1.24 
              
 Age at first induced miscarriageabortion 
 < 20    9 22.5  13 24.5   38 27.8  31 27.0  1.15 0.74, 1.81 
 20-29  18 45.0  24 45.3   68 49.6  46 40.0  0.94 0.66, 1.33 
 30+  13 32.5 16 30.2  31 22.6 38 33.0 1.38 0.90, 2.1 
              
 Age at last induced miscarriageabortion 
 < 20   5 12.5  10 18.9   28 20.4  22 19.1  1.10 0.65, 1.87 
 20-29  15 37.5  20 37.7   62 45.3  46 40.0  1.05 0.72, 1.54 
 30+  20 50.0  23 43.4   47 34.3  47 40.9  1.19 0.85, 1.67 
              
 Timing of first induced miscarriage abortion relative to first full-term birth
 Before   16 40.0  22 41.5   70 51.1  55 47.8  1.13 0.80, 1.60 
 After   24 60.0 31 58.5  67 48.9 60 52.2 1.09 0.79, 1.49 
              
 Gestational length of first induced miscarriageabortion
 ≤ 2 months  31  81.6 44 83.0  97 78.2 73 72.3 1.01 0.76, 1.34 
 > 2 months   7  18.4   9 17.0   27 21.8  28 27.7  1.28 0.78, 2.1 
              
Nulliparous Number of induced miscarriagesabortions 
 0c  156 90.6 123 94.6  145 80.1 233 88.9  1.0  
 1  16  9.4    7  5.4   36 19.9  29 11.1  0.80 0.47, 1.38 
 Trend in 
riskQuantiati
ved 
          1.05 081, 1.36 
              
 Age at first induced miscarriageabortion 
 < 20    2 12.5   0  0.0    8 24.2   6 26.1  0.60e  0.18, 2.0 
 20-29   10 62.5   7 100.0   22 66.7  14 60.9  0.54e  0.24, 1.19 
 30+    4 25.0   0   0.0    3  9.1   3 13.0  0.65e  0.11, 3.7 
              
 Age at last induced miscarriageabortion 
 < 20    1  6.2   0  0.0    5 15.2   5 21.7    
 20-29    7 43.8   6 83.3   21 63.6   9 39.1  0.58 0.29, 1.14 
 30+    8 50.0   1 16.7    7 21.2   9 39.1  1.29 0.48, 3.5 
              
 Gestational length of first induced miscarriageabortion
 ≤ 2 months   11 68.8  4 57.1   22 71.0  14 66.7 0.73 0.36, 1.47 
 > 2 months    5 31.2   3 42.9     9 29.0     7 33.3  1.33 0.75, 2.3 
              
CI=95% Confidence Interval; OR=Odds Ratio..  
a No deviance differences, with degrees of freedom, approached significance. 
b  Conditional logistic analysis controlled for duration of OC use in years, tubal ligation, hysterectomy, smoking, alcohol use, parity 
(1,2,3,4,5+), menopausal status, age at last birth >/= 30 years. 
c Reference category for all odds ratios  
d  Per induced miscarriage abortion  
e  ORs here only from case control study 2. 
 23
Table 4.  Summary of Published Population-Based Studies Exploring the Risk of Incomplete Pregnancies and OvarianCancer (Medline Search 1966 – September 2007) 
 
   All women 
(or a ever gravid women) 
Parous women Nulliparous women  
First author, 
year, (ref) 
study place. 
Referenc
e Years 
(Age 
Range) 
Total no. 
cases / non-
cases 
Outcome Freq (no. 
of cases 
where 
specified) 
OR / 
RR  
 
95% CI 
 
Outcome Freq (no. of 
cases where 
specified) 
OR 
/ RR 
 
95% CI Outcome Freq (no. of 
cases where 
specified) 
OR 
/  
RR 
95% CI Adjustment 
Cohort Studies                
Rosenblatt, 
2006,(11)(11) 
China 
1989 – 
2000 
(~31-75) 
Cases: 285 
OC 
Cohort: 
267,400  
Induced 
abortions 
0 (140) 
≥1 (145) 
1.0 
0.97  
 
0.76, 1.24 
        Age and parity.  Restricted 
to women with ≥1 
pregnancy and without 
prior bilateral 
oophorectomy. 
Kvale, 
1988,(10)(10) 
Norway 
1961-
1980 
(27-69 on 
1 Jan 
1956) 
Cases: 445 
OC all types 
Cohort: 
60,565  
Abortion  0 
≥1 
1.0 
0.89  
 
 
0.69, 1.16 
        Demographic variables and 
parity. 
Population-
Based Case-
Control 
Studies 
               
xxxxx, 2008, , 
Australia 
1990-
1993 and 
2002-
2005 
(18-79) 
Cases: 2300 
EOC 
Controls: 
2263 
    Incomplete 
pregnancies 
0 (1258) 
1 (441) 
2 (155) 
3+ (93) 
quantitativeT
rend in risk 
1.0 
1.02 
0.90 
0.93 
0.99 
 
0.86, 1.20 
0.70, 1.17 
0.68, 1.28 
0.93, 1.06 
Incomplete 
pregnancies 
0 (280) 
1 (42) 
2 (31) 
Trend in 
riskQuantitat
ive 
1.0 
0.72  
1.14  
1.05 
 
0.40, 1.29 
0.60, 2.20 
0.85, 1.28 
Duration of OC use in 
years, tubal ligation, 
hysterectomy, smoking, 
alcohol use, parity 
(1,2,3,4,5+), menopausal 
status, age at last birth >/= 
30 years 
       Spontaneous 
miscarriagesabo
rtions 
0 (1401) 
1 (389) 
2 (96) 
3+ (61) 
Trend in 
riskquantitati
ve 
1.0 
0.97 
0.93 
0.94 
0.97 
 
0.80, 1.17 
0.75, 1.15 
0.61, 1.46 
0.90, 1.04 
Spontaneous 
abortionsmis
carriages 
0 (329) 
1 (17) 
2 (7) 
Trend in 
riskQuantitat
ive 
1.0 
0.89  
1.05  
1.11  
 
0.35, 2.30 
0.36, 3.10 
0.76, 1.61 
 
       Induced 
abortionsmiscar
riages 
0 (1753) 
1 (136) 
2 (58) 
Trend in 
riskquantitati
ve 
1.0 
1.08 
1.22 
1.08 
 
0.82, 1.41 
0.80, 1.84 
0.94, 1.24 
Induced 
abortionsmis
carriages 
0 (389) 
1 (45) 
Trend in 
riskQuantitat
ive 
1.0 
0.8  
1.05  
 
0.47, 1.38 
0.81, 1.36 
 
Gierach, 
2005,(16)(16)  
USA (Delaware 
Valley) 
1994-
1998 
(20-69) 
 
 
Cases: 739 
EOC 
Controls: 
1313 
 
Incomplete 
pregnancy a 
(Excluded 
women with 
history of both 
spontaneous and 
induced 
abortions) 
0 (366) 
1 (140) 
2 (43) 
≥3 (14) 
ever (197) 
1.0 
0.94  
1.09  
0.69  
0.95  
 
0.74, 1.21 
0.73, 1.64 
0.36, 1.32 
0.76, 1.18 
    Incomplete 
pregnancy 
 
0 (176) 
≥1 (47) 
 
1.0 
1.12  
 
0.66, 1.89 
Age, number of livebirths/ 
stillbirths, duration of OCP 
use, race, tubal ligation, 
family history of ovarian 
cancer, educational level. 
   Spontaneous 
abortion a  
 
0 (366) 
1 (88) 
≥2 (37) 
ever (125) 
1.0 
0.83  
0.87  
0.84  
 
0.62, 1.11 
0.57, 1.32 
0.65, 1.09 
    Spontaneous 
abortion 
0 (176) 
≥1 (14) 
 
1.0 
1.77  
 
0.60, 5.20 
 
   Induced abortion 
a  
0 (366) 
1 (52) 
1.0 
1.30 
 
0.87, 1.94 
    Induced 
abortion 
0 (176) 
≥1 (33) 
1.0 
0.98 
 
0.55, 1.75 
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≥2 (20) 
ever (72) 
1.32 
1.31 
0.73, 2.38 
0.91, 1.86 
 
Riman, 
2002(19)(19) 
and 
2001(57)(57) 
Sweden 
1993-
1995 
(50-74) 
Cases: 655  
INV OC 
Controls: 
3899  
Abortions 
(spontaneous or 
induced) 
 
0 (547) 
1  (86) 
≥2  (22) 
1.0 
0.76 
0.70 
 
0.59, 0.98 
0.44, 1.12 
        Age, parity, BMI, age at 
menopause, duration of 
OCP use and ever use of 
HRT. 
  Cases: 193 
BL  
Controls: 
3899  
Abortions 
(spontaneous or 
induced) 
 
0  (157) 
1 (28) 
≥2 (8) 
1.0    
0.84  
0.78  
 
0.54, 1.29 
0.35, 1.71 
        Age, parity, BMI, age at 
menopause, + ever use of 
OCPs, unopposed 
oestrogens with cyclic 
progestins, or oestrogens 
with continuous 
progestins. 
Titus-Ernstoff., 
2001,(23)(23) 
USA 
(Massachesetts 
and New 
Hampshire) 
1992-
1997 
(20-74) 
Cases: 563 
EOC 
including 
BL 
Controls: 
523 
Miscarriage 
 
 
Abortion 
0 (427) 
≥1 (136)
  
0 (499) 
≥1 (64) 
1.0 
1.0 
 
1.0 
1.1 
 
0.70, 1.30 
 
 
0.70, 1.60 
        Age, state, and full term 
live-singleton births. 
Chen , 
1996,(13)(13) 
USA 
(Washington 
State) 
1986-
1988 
(20-79) 
Cases: 322 
INV or BL 
EOC 
Controls: 
426 
Induced 
abortion a 
 
0 (230) 
1 (23) 
≥2 (12) 
ever (35) 
1.0 
1.0  
1.2  
1.0  
 
0.50, 1.70 
0.50, 2.50 
0.60, 1.70 
Incomplete 
pregnancy  
(n = 583) 
 
0 
1 
≥2 
ever 
 
1.0 
1.4  
0.8 
1.1 
 
 
0.90, 2.10 
0.50, 1.40 
0.80, 1.60 
Incomplete 
pregnancy 
(n = 164) 
0 
1 
≥2 
ever 
 
1.0 
0.9 
0.8 
0.8 
 
 
0.40, 2.00 
0.30, 2.10 
0.40, 1.70 
Induced abortion  and 
incomplete pregnancy data 
adjusted for age, OC use, 
number of pregnancies / 
births (as applicable). 
Spontaneous abortion data 
also adjusted for marital 
status, and BMI. 
   Spontaneous 
abortion a  
0 (187) 
1 (55) 
≥2 (23) 
ever (78) 
 
1.0 
1.6 
0.8  
1.3 
 
1.00, 2.50 
0.40, 1.40 
0.80, 1.90 
         
Risch, 
1994,(20)(20) 
Canada 
1989-
1992 
(35-79) 
Cases: 450 
EOC 
Controls: 
564 
Miscarriage 
 
Induced 
abortion   
Trend in 
risk for 
each 
Trend in 
risk for 
each 
1.04 
 
1.00 
0.88, 1.24 
 
0.77, 1.30 
Miscarriage 
 
Induced 
abortion    
Trend in risk 
for each  
Trend in risk 
for each  
1.04  
 
0.98 
0.88, 1.24 
 
0.75, 1.29 
    Age group, age as a 
continuous variable, total 
duration of OCP use, 
number of full-term 
pregnancies. 
Chen, 
1992(14)(14) 
China (Beijing) 
1984-
1986 
(mean ~ 
49) 
Cases: 112 
EOC  
Controls: 
224 
 
Miscarriage 
 
  
0 (97) 
1 (11) 
≥2 (4) 
Trend test 
1.0 
0.4 
0.9 
p=0.64 
 
0.20, 1.10 
0.20, 3.60 
        Education and parity 
   Induced abortion 
 
0 (71) 
1 (24) 
2 (12) 
≥3 (5) 
Trend test 
1.0 
0.8 
0.8  
0.5  
p=0.39 
 
0.40, 1.50 
0.40, 1.90 
0.20, 1.60 
         
Whittemore, 
1992,(4)(4)  
USA 
Pooled analysis 
of 12 USA 
studies, 6 being 
population-
based (12, 15, 
1973-
1985 
(18-79) 
Cases: 1400 
INV EOC 
Controls: 
5600 
Failed 
pregnancies  
(abortions, 
miscarriage, 
ectopic 
pregnancies and 
stillbirth) 
0 (1011) 
1-2 (307) 
≥3 (52) 
Any (359) 
Trend 
/failed 
pregnancy 
1.0 
0.88 
0.83 
0.87 
0.94  
(P = 
0.09) 
 
0.75, 1.00 
0.59, 1.20 
0.75, 1.00 
 
 
 
 
 
 
 
   Failed 
pregnancies 
0 (271) 
Ever (51) 
1.0 
1.4 
 
0.91, 2.10 
Age, study, parity and 
OCP use (and marital 
status for nulliparous 
women)  
 
 
 
 25
18, 22, 24, 
25)(12, 15, 18, 
22, 24, 25)  
Shu, 
1989,(21)(21) 
China 
(Shanghai) 
1984-
1986 
(18-70) 
Cases: 172 
EOC 
Controls: 
172 
     Miscarriages 
and stillbirths 
0 (144) 
1 (20) 
≥2 (8) 
Trend test 
1.0 
1.3 
1.0  
P = 
0.77 
 
0.60, 2.90 
0.30, 3.40 
    Education, ovarian cyst, 
age at menarche, number 
of livebirths. 
       Induced 
abortions 
0 (122) 
1 (35) 
≥2 (15) 
Trend test 
1.0 
0.7 
0.6 
P = 
0.14 
 
0.40, 1.40 
0.20, 1.30 
     
Harlow, 
1988,(17)(17) 
USA 
(Washington) 
1980- 
1985 
(20-79) 
Cases: 116 
BL only 
Controls: 
158 
Induced 
abortions a 
0 (76) 
1 (12) 
≥2 (5) 
1.0 
1.2 
0.9 
 
0.50, 3.10 
0.20, 3.70 
        Age and gravidity. 
   Miscarriages a  0 (61) 
1 (22) 
≥2 (10) 
1.0 
2.2 
3.0 
 
1.00, 5.10 
0.90, 11.2 
         
Newhouse, 
1977,(46)(46)  
United 
Kingdom 
NS 
(<45 – 
65+) 
Cases: 300 
OC 
Controls: 
300  
Miscarriages 0 (ca 240) 
≥1 (ca 60) 
 
1.0 
1.41b 
 
0.85, 2.33 
b  
        Nil specified. 
 
BL = borderline; CI = confidence intervals; EOC = epithelial ovarian cancer; INV = invasive; LMP = low malignant potential; NS = not specified; OC = ovarian cancer;  OCP = oral contraceptive pill; OR = odds ratio; RR = relative risk 
a in ever gravid women 
b  Result/s calculated from published study data 
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Table 5.  Summary of Published Hospital-Based Case Control Studies Exploring the Risk of Incomplete Pregnancies and Ovarian Cancer (Medline Search 1966 – September 2007) 
 
  All women 
(a  or  ever gravid women) 
Parous women Nulliparous women  
First 
author 
year, (ref) 
study 
place. 
Reference 
Years 
(Age Range) 
Total no. cases / 
non-cases 
Outcome Freq (no. 
of cases) 
OR/RR 
 
95% CI Outcome Freq (no. 
of cases) 
OR / 
RR 
 
95% CI Outcome Freq (no. 
of cases) 
OR/
RR 
 
95% CI Adjustment 
El-Khwsky, 
2006,(30)(3
0) Egypt 
2000 – 2003 
(20-79) 
Cases: 172 EOC 
Controls: 441 
Fetal losses 
(abortion) 
0    (103) 
1-3 (62) 
4+  (7) 
Χ2 trend 
1.0 
1.7 
3.7 
12.2 (P< 
0.001) 
 
1.16, 2.59 
1.02, 13.45 
 
        Nil specifically noted, but 
paper states univariate and 
multivariate analyses were 
performed. 
Zhang, 
2004,(45)(4
5) China 
1999-2000 
(< 70) 
Cases: 254 EOC 
Controls: 652 (51 
population-based) 
Incomplete 
pregnancies 
0     (98) 
1     (79) 
≥2  (77) 
1.0 
0.69 
0.56 
 
0.47, 1.00 
0.39, 0.82 
        Age, locality, education, 
family income, BMI, total 
energy intake, tobacco 
smoking, alcohol 
consumption, ovarian 
cancer in first degree 
relatives. 
Yen, 
2003,(44)(4
4) Taiwan 
1993-1998 
(20-75) 
Cases: 86 INV 
EOC 
Controls: 369 
Incomplete 
pregnancies 
0    (46) 
≥1 (40) 
Any 
 
1.0 
1.42 
 
0.86, 2.32 
        Age, income during 
marriage, education, 
number of live births. 
Chiaffarino, 
2001,(29)(2
9)  
Italy 
1992-1999 
(17-79) 
Cases: 1031 EOC 
Controls: 2411 
Spontaneous 
abortions 
0   (795) 
1   (167) 
≥2 (69) 
1.0 
1.0 
0.9 
 
0.80, 1.30 
0.70, 1.20 
        Age, centre, education, 
parity, OC use, family 
history of ovarian and 
breast cancer in first 
degree relatives. 
   Induced 
abortions 
0   (916) 
1   (66) 
≥2 (49) 
1.0 
1.1 
1.1 
 
0.80, 1.60 
0.70, 1.60 
         
Greggi, 
2000,(31)(3
1)  
Italy 
(Rome) 
1988-1998 
(13-80) 
Cases: 440 EOC 
Controls:868 
Spontaneous 
abortions 
0   (349) 
1   (65) 
≥2 (26) 
1.0 
1.0 
0.9 
 
0.70, 1.50 
0.50, 1.50 
        Age, education, parity, OC 
use and duration, family 
history of ovarian cancer, 
age at first birth, breast 
feeding, spontaneous / 
induced abortions. 
Salazar-
Martinez, 
1999,(39)(3
9) Mexico 
1995-1997 
(mean ~53) 
Cases: 84 EOC 
Controls: 668 
Miscarriages 
(not defined) 
0     (62) 
1     (10) 
≥2  (12) 
Χ2 trend 
1.0 
0.61 
0.90 
P=0.21 
 
0.30, 1.20 
0.44, 1.8 
        Age, hormonal use, 
breastfeeding, smoking, 
diabetes mellitus, 
hypertension, physical 
activity, menopausal 
status, body build index. 
Bernal, 
1995,(26)(2
6) Mexico 
City 
1989 – 1992 
(18-79) 
Cases: 172 EOC 
Controls: 441 
Abortions 0 
≥1 
1.0 
1.82 
P=0.008 
 
1.17, 2.82 
Abortions 0     (68) 
1-3  (59) 
4  (7) 
Χ2 trend 
1 
2.05 
5.44 
17.70 
(P<0.0
01) 
 
1.33, 3.16 
1.43, 22.28 
    Nil listed for parous 
women.  
Logistic regression 
undertaken for all women, 
but actual variables 
adjusted for not specified. 
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Polychrono
poulou, 
1993,(38)(3
8) Greece 
 
1989-91 
(< 75) 
Cases: 189 EOC 
Controls: 200 
Miscarriages 0   (124) 
1   (42) 
≥2 (23) 
1.0 
1.61 
1.30 
 
0.92, 2.81 
0.66, 2.53 
        Age  
   Induced 
abortions 
0   (126) 
1   (20) 
2   (21) 
≥3 (22) 
1.0 
0.87 
1.05 
0.90 
 
0.44, 1.71 
0.53, 2.08 
0.46, 1.79 
        Age  
Whittemore
, 
1992,(4)(4) 
USA 
Pooled 
analysis of 
12 studies, 
5 of which 
were 
hospital-
based and 
contributed 
incomplete 
pregnancy 
data.(28, 
32, 33, 35, 
42)(28, 32, 
33, 35, 42) 
 
1956-1986 
(18-85) 
 
 
Cases:  705 INV 
EOC 
Controls: 2783 
Failed 
pregnancies 
(abortions, 
miscarriages, 
ectopic 
pregnancies, 
and stillbirths) 
 
0     (482) 
1-2 (191) 
≥3 (3.2) 
Any (223) 
Trend / 
failed 
pregnancy 
 
1.0 
0.86 
0.80 
0.86  
0.93 P=0.19
 
0.68, 1.10 
0.50, 1.30 
0.68, 1.1 
 
    Failed 
pregnancies 
(excluding 
{McGowan, 
1979) 
0 (159) 
≥1 (29) 
1.0 
0.82 
 
0.46, 1.50 
Age, study, parity, OCP 
use (and marital status for 
nulliparous women) 
Negri, 
1991,(47)(4
7) Italy, UK 
and Greece.  
Pooled 
analysis of 
3 
studies.(27, 
37, 40)(27, 
37, 40) 
1978-
1989 
(~ <75) 
Cases: 1140 EOC 
Controls: 2724 
Abortions 0   (805) 
1   (184) 
≥2 (100) 
Χ2 trend 
1 
0.9 
0.7 
7.93 
(P<0.01) 
 
0.80, 1.10 
0.60, 0.90 
Abortions 0   
1   
≥2  
Χ2 trend 
1 
0.9 
0.7 
7.39 
P<0.01 
 
0.70, 1.10 
0.50, 0.90 
Abortions 0   
1   
≥2  
 
1 
1.1 
0.7 
 
0.60, 2.00 
0.30, 1.50 
Age, study centre, 
sociocultural indicators, 
age at menopause, OCP 
use for all shown analyses 
(and parity, number of 
abortions, age of first birth 
for all women and parous 
women). 
Mori, 
1988,(36)(3
6) Japan 
(Hokkaido) 
 
 
1980- 
1981, 
1985-
1986 
(mean 
~51) 
Cases: 110 EOC 
Controls: 220 
 
Miscarriage 
(98 case/control 
sets of ever 
married 
women) 
0 (69) 
≥1 (29)  
1.0 
0.8 
 
0.50, 1.40 
        Nil  
   Induced 
abortion 
0 (60) 
1 (38)   
1.0  
0.6 
P=0.04 
         Marital status, number of 
live births, experience of 
tubal ligation. 
Newhouse, 
1977,(46)(4
6) United 
Kingdom 
 
NS 
(<45 – 
65+) 
Cases: 300 OC 
Controls: 300  
Miscarriages 0 (ca 240) 
≥1 (ca 60) 
 
 
1.0 
1.22 b  
 
0.73, 2.04 
b 
        Nil specified. 
Joly, 
1974,(34)(3
4) USA 
(Buffalo, 
New York) 
1957-
1965 
(mean ~ 
53) 
Cases:276 OC 
Controls: 273  
Miscarriages 
(in ever-
pregnant 
women) 
0 (237) 
≥1 (39) 
1.00 
1.30 b,c,  
 
0.86, 1.95 
b, c 
        Nil specified. 
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Wynder, 
1969,(43)(4
3) USA 
(New York)  
NS (3 
year span) 
(<29 – 
70+) 
Cases: 150 EOC 
Controls: 300 
Spontaneous 
abortion 
0   (78) 
≥1 (39) 
1.0 
1.69 b  
 
1.03, 2.76 
b 
        Nil specified 
   Induced 
abortion 
Married, ever 
pregnant 
women 
0   (103) 
≥1 (14) 
 
1.0 
1.18b 
 
 
0.58, 2.39 
         
West, 
1966,(41)(4
1) USA 
(Boston) 
1959-
1960 
(<76) 
Cases: 97 OC 
Controls: 97 
 
Abortions and 
miscarriage 
 
 P>0.3          Nil specified. 
 
BL = borderline; CI = confidence intervals; EOC = epithelial ovarian cancer; INV = invasive; LMP = low malignant potential; NS = not specified; OC = ovarian cancer;  OCP = oral contraceptive pill; OR = odds ratio; RR = relative risk 
a in ever gravid women 
b  Result/s calculated from published study data 
c  Based on data presented for cancer of the ovary class II 
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